Guide · before you pay

Thirteen things a GLP-1 service should tell you before you pay

Every review on this site is measured against the same thirteen questions. Across 87 services, not one answers all thirteen — so this is less a checklist of what to expect than a map of where the silences reliably fall.

Updated 2026-08-235 sources

Buying a prescription medicine through a website is a strange transaction. The thing being sold is partly the drug and partly the clinical judgement around it, and only one of those has a price on the page. The thirteen questions below are the ones that turned out to matter while reading the market, and each one is checked against every service reviewed here.

The aggregate result is the finding. The mean service publishes 7.6 of the thirteen. None publishes all thirteen, and the gaps are not randomly distributed — they cluster hard around money you get back and care you receive.

The thirteen, and how often each is answered

Checklist items, with the share of reviewed services that publish each
What to ask	Publishes it	Why it matters
How the consultation works	84 of 87	Is it a live visit, a video call or an asynchronous questionnaire — and can a prescription be issued without anyone speaking to you?
Who it will and will not treat	78 of 87	What the stated thresholds are, and which histories are refused. An intake that never mentions medullary thyroid carcinoma or MEN 2 is not screening for the boxed warning.
Who the prescriber is	82 of 87	Whether you get a named clinician, whether they are licensed in your state, and whether you can reach the same one twice.
Whether any bloodwork is done	13 of 87	Baseline labs are not universal in this market. Ask whether any are ordered, and who reads them.
Which pharmacy dispenses	40 of 87	The named pharmacy or outsourcing facility, and whether the product is FDA-approved or compounded. “FDA-registered facility” is not the same claim as an approved medicine.
How the medicine gets to you	51 of 87	Cold chain, tracking, and what happens when a box is late or arrives warm. This is a clinical question, not a logistics one — a gap in supply can mean restarting titration.
What support exists between visits	60 of 87	Who answers when the nausea does not settle, how fast, and whether that channel reaches a clinician or a support agent.
The membership fee	67 of 87	What the subscription costs on its own, separately from medication, and whether it continues during a pause.
The medication price	78 of 87	The price of the maintenance dose, not the starting dose. Advertised figures in this market frequently attach to the titration months only.
How to cancel	37 of 87	The actual mechanism, any notice period, and whether cancelling requires a phone call that is only answered during office hours.
Whether anything is refundable	16 of 87	Especially on a prepaid multi-month plan, and especially if supply becomes unavailable partway through.
Whether insurance is accepted	46 of 87	Whether the service bills insurance, helps with prior authorisation, or is cash-only and says so.
Whether HSA or FSA funds work	11 of 87	And whether the service issues the itemised receipt you would need to claim.

Computed from the researched dataset at build time, so these counts cannot drift away from the reviews they summarise. A service is counted as publishing an item only where we could find it stated on a retrievable page.

Where the silence concentrates

Three items sit far below the rest. Only 11 of 87 services say whether HSA or FSA funds can be used; only 13 mention bloodwork of any kind; only 16 publish a refund position. Compare that with 84 that describe the consultation and 78 that publish a medication price, and the shape of the market is visible: the parts that help you buy are documented, and the parts that help you leave, or that cost the provider money, are not.

Cancellation is the sharpest version of this. 37 of 87 services explain how to cancel, which means a majority of the market asks for a recurring payment without publishing how to stop it. Whether cancelling is easy is one of the two things this site declines to score, precisely because it cannot be assessed from a marketing page — the reasoning is on the methodology page.

Who publishes the most

Highest disclosure counts among reviewed services
Service	Publishes	Still silent on
LifeMD	12 of 13	whether hsa or fsa funds work
Maximus	12 of 13	how to cancel
Aspire Health	10 of 13	what support exists between visits, the membership fee, whether hsa or fsa funds work
Cora Health	10 of 13	whether any bloodwork is done, which pharmacy dispenses, whether anything is refundable
CoreAge Rx	10 of 13	who it will and will not treat, whether any bloodwork is done, whether hsa or fsa funds work
Embody	10 of 13	whether any bloodwork is done, which pharmacy dispenses, whether anything is refundable

A disclosure count, not a recommendation. It says these companies answered more of the questions, not that the answers were good ones — read the review for that.

Lowest disclosure counts among reviewed services
Service	Publishes	Silent on
Hers	4 of 13	who the prescriber is, whether any bloodwork is done, which pharmacy dispenses, how the medicine gets to you, what support exists between visits, how to cancel, whether anything is refundable, whether insurance is accepted, whether hsa or fsa funds work
MyPharmacy	4 of 13	how the consultation works, who it will and will not treat, who the prescriber is, whether any bloodwork is done, what support exists between visits, how to cancel, whether anything is refundable, whether insurance is accepted, whether hsa or fsa funds work
Wisp	4 of 13	whether any bloodwork is done, which pharmacy dispenses, what support exists between visits, the membership fee, the medication price, how to cancel, whether anything is refundable, whether insurance is accepted, whether hsa or fsa funds work
Medino	3 of 13	how the consultation works, who it will and will not treat, who the prescriber is, whether any bloodwork is done, how the medicine gets to you, what support exists between visits, how to cancel, whether anything is refundable, whether insurance is accepted, whether hsa or fsa funds work
InjectCo	2 of 13	how the consultation works, who it will and will not treat, who the prescriber is, whether any bloodwork is done, which pharmacy dispenses, how the medicine gets to you, what support exists between visits, how to cancel, whether anything is refundable, whether insurance is accepted, whether hsa or fsa funds work

Where a company blocks automated retrieval, the reviews rest on a dated archive snapshot and say so at the top. A low count here means little was published, not that little was looked for.

How to use this before you pay

Ask about the maintenance dose, not the starting dose. Every ladder in Every dose step, and what to do when you miss one begins at a dose nobody stays on, and the advertised price frequently attaches to that dose.
Ask what happens if supply stops mid-plan. This is not hypothetical: the legal basis for bulk-compounding these molecules is the subject of an open FDA proposal, set out in Brand-name vs compounded GLP-1s.
Ask who reads a result at 2 a.m. Support is the field where a published answer and a real answer diverge most, and the consequences are in GLP-1 side effects, sorted by what to do about them.
Ask for the pharmacy by name, then check it. In Britain that check takes about a minute against the GPhC register — How to tell a regulated GLP-1 seller from a risky one explains how.
Get the cancellation mechanism in writing before the first payment, not after the third.

If a service answers all of these to your satisfaction, the next question is price against the rest of the market — Every researched GLP-1 provider, side by side puts every reviewed service in one table, and The cheapest GLP-1 programmes, with the memberships added back in adds the memberships back in.

Questions

Does a high disclosure count mean a service is good?

No, and the page says so at the top. It counts published facts. Two things this site considers central — how hard it is to cancel, and how a clinician responds when something goes wrong — cannot be measured from a marketing page, which is why no score is published for the researched reviews at all.

Why is bloodwork so rarely mentioned?

Because for most of this market it is not part of the product. 13 of 87 services mention labs at all. That is not automatically wrong — plenty of prescribing happens without baseline bloods — but it is a difference between services that a price comparison will not show you.

What if a service answers these questions by email but not on its site?

Then you have an answer and the next customer does not. Take it in writing. This site only counts what is published, because a private answer is not verifiable and cannot be held to.

Sources

Everything on this page traces to one of the links below, retrieved on the date shown. Prices and programme terms in this market change without notice — confirm against the provider before you buy.

01FDA — “Telehealth Companies: What to Know When Promoting Compounded Drugs” (cited from the search index)retrieved 2026-08-16
02FDA — “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss” (cited from search index; fda.gov refused direct retrieval)retrieved 2026-08-14
03ASA — Advertising advice, “Weight control: Prescription-only medicines”, setting out CAP Code rule 12.12retrieved 2026-08-16
04General Pharmaceutical Council — register of pharmacies and pharmacy professionalsretrieved 2026-08-16
05WEGOVY® (semaglutide) injection and tablets — US prescribing information, Novo Nordisk, revised 06/2026retrieved 2026-08-23